NTBL (Notable Labs Inc.) Yalpi rentabellik

Notable Labs Inc. (NTBL) korporativ emblemasi va logotipi

Notable Labs, Ltd. (NTBL) kompaniyasining yalpi foyda marjasi taqsimoti biotexnologiya sektorining inqirozlarga chidamliligini namoyish etadi, bunda 0.00 eng so'nggi metrika qiymatini aks ettiradi. Biznes samaradorligi tibbiyot hamjamiyatining uning algoritmlarini tan olishiga va biologik namunalarga kirish imkoniyatiga asoslangan. Joriy o'sish IT modellarining kengayishi va shifoxonalar bilan tuzilgan B2B shartnomalariga tayanadi, bu esa kompaniyaning bozor qiymatini uning daromadlilik prizmasi orqali belgilaydi.

NTBL: Notable Labs Inc. Yalpi marja 21.02.2024 - 02.11.2024

Notable Labs, Ltd. (NTBL) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- bozor qiymati va tahlilchilarning maqsadli prognozi:
Fundamental baholash:Notable Labs, Ltd.
Notable Labs Corp tomonidan chiqariladigan mahsulotlar

Funktsional tirik hujayralar diagnostikasi orqali aniq onkologik terapiyani ishlab chiquvchi Notable Labs, Ltd. (NTBL) uchun ushbu ko'rsatkich shaxsiylashtirilgan davolashning monetizatsiya samaradorligini aks ettiradi. Ushbu metrika umumiy daromad va bevosita test ishlab chiqarish xarajatlari orasidagi farq sifatida hisoblanadi va operatsion xarajatlarni qoplash uchun mavjud bo'lgan kapital qismini belgilaydi. Valo daromad marjasini tahlil qilish orqali investor biznes modelining kengayish imkoniyatlarini va aktivning ichki qiymati kamayishi xavfini aniqlaydi.

Toʻgʻridan-toʻgʻri raqobatchilar

Yalpi foyda marjasi BeiGene Ltd. (ONC)|Yalpi foyda bo'yicha rentabellik HALO|Yalpi rentabellik RVMD|Yalpi foyda bo'yicha rentabellik AAPG (Ascentage)|Yalpi foyda bo'yicha rentabellik cgoncology.com CGON|UroGen Pharma - Yalpi foyda bo'yicha rentabellik|Yalpi foyda normasi BCAX|PSNL - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi Erasca Oncology ERAS|delcath.com (DCTH) - Yalpi rentabellik|Y-mAbs Therapeutics - Yalpi foyda normasi|AURA (Aura Biosciences Inc) - Yalpi marja|Yalpi foyda marjasi candeltx.com CADL|Yalpi marja ARAY|SLS (SELLAS Life Sciences Group, Inc.) - Yalpi foyda normasi|Yalpi rentabellik Actuate Therapeutics, Inc. ACTU|citiusonc.com - Yalpi rentabellik|TuHURA Biosciences Inc. - Yalpi marja|TARA - Yalpi marja|FATE (Fate Therapeutics) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha rentabellik Aadi Bioscience, Inc.|Yalpi foyda bo'yicha rentabellik TCRX|Yalpi rentabellik CSBR|Yalpi marja XBIT|Yalpi foyda bo'yicha sotuv rentabelligi CEL-SCI Corp.|Yalpi rentabellik ostherapies.com OSTX|RADX: Sotuvning yalpi rentabelligi|ARTV: Yalpi foyda bo'yicha rentabellik|ANL (Adlai Nortye) - Sotuvning yalpi rentabelligi|Veru (VERU) - Yalpi rentabellik|Yalpi foyda bo'yicha rentabellik Tempest Therapeutics Inc|Yalpi rentabellik Xilio Therapeutics|Sotuvning yalpi rentabelligi RENB (Renovaro Inc.)|Yalpi rentabellik Mural Oncology PLC (MURA)|Yalpi marja Kairos Pharma (KAPA)|Yalpi rentabellik onkuretherapeutics.com OKUR|GDTC: Sotuvning yalpi rentabelligi|CRIS: Yalpi foyda bo'yicha rentabellik|apollomicsinc.com (APLM) - Yalpi foyda bo'yicha rentabellik|THAR: Yalpi marja|Yalpi foyda bo'yicha rentabellik Advanced Biomed Inc.|Yalpi foyda bo'yicha rentabellik GNPX|Sotuvning yalpi rentabelligi CLDI (Calidi Biotherapeutics)|Yalpi marja SBFM|Xenetic Biosciences, Inc. - Sotuvning yalpi rentabelligi|Yalpi rentabellik Salarius Pharmaceuticals SLRX|Yalpi marja purple-biotech.com PPBT|AONC - Yalpi rentabellik|BGNE: Yalpi rentabellik|CKPT: Yalpi marja|Elevation Oncology - Yalpi foyda normasi|ICAD (iCAD) - Yalpi marja|IKNA: Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik VIRX (Viracta Therapeutics Inc.)|MOR - Yalpi foyda marjasi|Yalpi rentabellik NAYA Biosciences NAYA|AAPGV - Yalpi foyda bo'yicha rentabellik